TU-100 (Daikenchuto) and ginger ameliorate anti-CD3 antibody induced T cell-mediated murine enteritis: Microbe-independent effects involving Akt and NF-kB suppression

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ueno, Nobuhiro ^a,b   Hasebe, Takumu ^a,b   Kaneko, Atsushi ^c   Yamamoto, Masahiro ^c   Fujiya, Mikihiro ^b   Kohgo, Yutaka ^b   Kono, Toru ^b,d   Wang, Chong Zhi ^e   Yuan, Chun Su ^e   Bissonnette, Marc ^a   Chang, Eugene B ^a   Musch, Mark W ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c TSUMURA AND CO   (Japan)

^d Sapporo Higashi Tokushukai Hospital   (Japan)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD3 ANTIBODY; DAIKENCHUTO; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD3 ANTIGEN; DAI-KENCHU-TO; MONOCLONAL ANTIBODY; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL MEDIATED CYTOTOXICITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; ENTERITIS; ENZYME INACTIVATION; ENZYME REPRESSION; FEEDING; FEMALE; GERMFREE ANIMAL; GINGER; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; JAPANESE MEDICINE; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; THERAPY EFFECT; TRADITIONAL MEDICINE; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; ENZYME ACTIVATION; IMMUNOLOGY; INTESTINE MUCOSA; JEJUNUM; METABOLISM; PATHOLOGY; T LYMPHOCYTE; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; APOPTOSIS; CELL LINE, TUMOR; ENTERITIS; ENZYME ACTIVATION; GINGER; HUMANS; INTESTINAL MUCOSA; JEJUNUM; MICE; NF-KAPPA B; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901413713     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097456     Document Type: Article

References (46)

1. Jin XL, Shibata C, Naito H, Ueno T, Funayama Y, et al. (2001) Intraduodenal and intrajejunal administration of the herbal medicine, dai-kenchu-tou, stimulates small intestinal motility via cholinergic receptors in conscious dogs. Dig Dis Sci 46: 1171-1176. (Pubitemid 32523260)
2. Murata P, Kase Y, Ishige A, Sasaki H, Kurosawa S, et al. (2002) The herbal medicine Dai-kenchu-to and one of its active components [6]-shogaol increase intestinal blood flow in rats. Life Sci. 70: 2061-2070. (Pubitemid 34215131)
3. Kono T, Koseki T, Chiba S, Ebisawa Y, Chisato N, et al. (2008) Colonic vascular conductance increased by Daikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein 1. J Surg Res 150: 78-84.
4. Kono T, Kanematsu T, Kitajima M (2009) Exodus of Kampo, traditional Japanese medicine, from complimentary and alternative medicines: is it time yet? Surgery 146: 837-840.
5. Manabe N, Camilleri M, Rao A, Wong BS, Burton D, et al. (2010) Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. Am J Physiol Gastrointest Liver Physiol. 298: G970-975.
6. Horiuchi A, Nakayama Y, Tanaka N (2010) Effect of traditional Japanese medicine, diakenchuto (TJ-100) in patients with chronic constipation. Gastroenterol Res 3: 151-155.
7. Kono T, Kaneko A, Hira Y, Suzuki T, Chisato N, et al. (2010) Anti-colitis and adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model. J Crohns Colitis 4: 161-170.
8. Kono T, Omiya Y, Hira Y, Kaneko A, Chiba S, et al. (2011) Daikenchuto (TU- 100) ameliorates colon microvascular dysfunction via endogenous adrenomedullin in Crohn's disease rat model. J Gastroenterol 46: 1187-1196.
9. Yasanoya H, Miyata H, Horiguchi H, Kuwabara K, Hashimoto H, et al. (2011) Effect of Japanese herbal Kampo medicine dai-kenchu-to on postoperative adhesive small bowel obstruction requiring long-tube decompression: a propensity score analysis. Evidence-Based Comp Alter Med doi.org/10.1155/ 2011/264286.
10. + T cell transfer into SCID mice. Dig Dis Sci 57: 2571-2579.
11. Kono T, Kaneko A, Omiya Y, Ohbuchi K, Ohno N, et al. (2012) Epithelial transient receptor potential ankyrin 1 (TRPA1) dependent adrenomedullin upregulates blood flow in rat small intestine. Am J Physiol Gastrointest Liver 304: G428-G436.
12. Iturrino J, Camilleri M, Wong BS, Linger Nord SJ, Burton D, et al. (2013) Randomised clinical trial: the effects of daikenchuto TU-100 on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation. Aliment Pharmacol Ther 37: 776-785.
13. Endo M, Hori M, Ozaki H, Oikawa T, Hanawa T (2013) Daikenchuto, a traditional Japanese herbal medicine, ameliorates postoperative ileus by antiinflammatory action through nicotinic acetylcholine receptors. J Gastroenterol doi 10.1007/s00535-013-0854-6.
14. Kaneko A, Kono T, Miura N, Tsuchiya N, Yamamoto M. (2013) Preventive effect of TU-100 on a type-2 model of colitis in mice: possible involvement of enhancing adrenomedullin in intestinal epithelial cells. Gastroenterol Res Practice doi 10.1155/2013/384057.
15. Kim S, Kundu JK, Shin YK, Park JH, Cho MH, et al. (2005) [6]-gingerol inhibits COX-2 expression by blocking the activation of p38MAP kinase and NF-kappaB in phorbol ester stimulated mouse skin. Oncogene 24: 2558-2567. (Pubitemid 40593046)
16. Wu H, Hsieh MC, Lo CY, Liu CB, Sang S, et al. (2010) 6-shogaol is more effective than 6-gingerol and curumin in inhibiting 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice. Mol Nut Food Res 54: 1296- 1306.
17. Huang HC, Chiu SH, Chang TM (2011) Inhibitory effect of [6]-gingerol on melanogenesis in B16F10 melanoma cells and a possible mechanism of action. Biosci Biotechnol Biochem 75: 1067-1072.
18. Hung JY, Hsu YL, Li CT, Ko YC, Ni WC, et al. (2009) 6-shogaol, an active constituent of dietary ginger, induces autophagy by inhibiting the AKT/mTOR pathway in human non-small lung cancer A549 cells. J Agr Food Chem 57: 9809-9816.
19. Li XH, McGrath KC, Tran VH, Li YM, Duke CC, et al. (2013) Attenuation of proinflammatory responses by S-[6]-gingerol via inhibition of ROS/NFKappaB/COX-2 activation in HuH7 cells. Evid Based Complement Alternat Med. doi: 10.1155/2013/146142.
20. Jin Y, Kotakdi VS, Ying L, Hofseth AB, Cui X, et al. (2008) American ginseng suppresses inflammation and DNA damage associated with mouse colitis. Carcinogenesis 29: 2351-2359.
21. Dougherty U, Mustafi R, Wang Y, Musch MW, Wang CZ, et al. (2011) American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFR. BMC CAM 11: 111.
22. Wang CZ, Du GJ, Zhang Z, Wen XD, Wen XD, et al. (2012) Ginsenoside compound K, not Rb1, possesses potential preventative activities in human colorectal cancer. Int J Oncol doi 10.3892/ijo.2012.1399.
23. Zhang Z, Du GK. Wang CZ, Wen XD, Calway T, et al. (2013) Compound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21interactions. Int J Mol Sci 14: 2980-2995.
24. Calixto JB, Kassuya CA, Andre E, Ferreira J (2005) Contibution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions. Pharmacol Ther 106: 179-208. (Pubitemid 40603864)
25. Riera CE, Menozzi-Smarrito C, Affolter MN, Michlig S, Munari C, et al. (2009) Compounds from Sichuan and Melegueta peppers activate, covalently and noncovalently, TRPA1 and TRPV1 channels. Br J Pharmacol 157: 1398+1409.
26. Radojevic N, McKay DM, Merger M, Valance BA, Collins SM, et al. (1999) Characterization of enteric functional changes evoked by in vivo anti-CD3 T cell activation. Am J Physiol Regul Physiol 275: R715-R723. (Pubitemid 29157500)
27. Musch MW, Clarke LL, Mamah D, Gawenis LR, Zhang Z, et al. (2002) T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+-K+-ATPase. J Clin Invest 110: 1739-1747. (Pubitemid 35424252)
28. Miura N, Yamamoto M, Fukutake M, Ohtake N, Iizuka S, et al. (2005) Anti-CD3 antibody induces biphasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments. Int Immunol 17: 513-522. (Pubitemid 41417848)
29. Clayburgh DR, Barrrett TA, Tang Y, Meddings JB, Van Eldik LJ, et al. (2005) Epithelial myosin light chain kinase dependent barrier dysfunction mediates T cell activation induced diarrhea in vivo. J Clin Invest 115: 2702-2715. (Pubitemid 41434398)
30. Tang Y, Clayburgh DR, Mittal N, Goretsky T, Dirisina R, et al. (2010) Epithelial NF-kB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation. Am J Pathol 176: 158-167.
31. Abramowicz D, Schandene L, Goldman M, Cruisaux A, Vereerstraeten P, et al. (1989) Release of tumor necrosis factor, interleukin-2, and gamma interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47: 606-608. (Pubitemid 19110914)
32. Charpentier B, Hiesse C, Lantz O, Ferran C, Stephens S, et al. (1992) Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome. Transplantation 54: 997-1002. (Pubitemid 23005535)
33. Petersen MD, Mooseker M. (1992) Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci 102: 581-600.
34. Pan MH, Hsieh MC, Hsu PC, Ho Sy, Lai CS, et al. (2008) 6-shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Mol Nutr Food Res 52: 1467-1477.
35. Weng CJ, Chou CP, Ho CT, Yen GC (2012) Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol. Mol Nut Food Res 56: 1304-1314.
36. Wang X, Hao J, Metzger DL, Ao Z, Chen L, et al. (2012) B7-H4 treatment of T cells inhibits ERK, JNK, p38, and Akt activation. PLOS One. doi 10.1371/journal.pone.0028232.
37. Lucas PC, McAllister-Lucas LM, Nunez G (2004) NF-kB signaling in lymphocytes: a new cast of characters. J Cell Sci 117: 31-39. (Pubitemid 38072118)
38. Iwabu J, Watanabe J, Hirakura K, Ozaki Y, Hanazaki K (2010) Profiling of the compounds absorbed in human plasma and urine after oral administration of a traditional Japanese (Kampo) medicine, daikenchuto. Drug Metab Disposition 38: 2040-2048.
39. Munekage M, Kitagawa H, Ichikawa K, Watanabe J, Aoki K, et al. (2011) Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after single oral administration to health Japanese volunteers. Drug Metab Dispos 39: 1784-1788.
40. Kim MK, Lee JW, Lee KY, Yang DC (2005) Microbial conversion of major ginsenoside Rb1 to pharmaceutically active minor ginsenoside Rd. J Microbiol 43: 456-462.
41. Wang L, Liu QM, Sung BH, An DS, Lee HG, et al. (2011) Bioconversion of ginsenoside Rb(1), Rb (2), Rc and Rd by novel beta-glucosidase hydrolyzing outer 3-O-glycoside from Sphingomonas sp. 2F2; cloning, expression, and enzyme characteristics. J Biotechnol 156: 125-133.
42. Quan LH, Min JW, Jin Y, Wang C, Kim YJ, et al. (2012) Enzymatic biotransformation of ginsenoside Rb1 to compound K by recombinant betaglucosidase from Microbacterium esteraromaticum. J Agric Food Chem 60: 3776-3781.
43. Chakakiyo M, Shimada M, Nakao T, Higashima J, Yoshikawa K, et al. (2012) Kampo medicine dai-kenchu-to prevents CPT-11 induced small intestinal injury in rats. Surg Today 42: 60-67.
44. Wang CC, Chen LG, Lee LT, Yang LL (2003) Effect of 5-gingerol, an antioxidant from ginger, on inducing apoptosis in human leukemic HL-60 cells. In Vivo 17: 641-645.
45. Masuda Y, Kikuzaki H, Hisamoto M, Nakatani N (2004) Antioxidant properties of gingerol related compounds from ginger. BioFactors 21: 293-296. (Pubitemid 40921871)
46. Dugasani S, Pickika MR, Nadarajah VD, Ballijepalli MK, Tandra S, et al. (2010) Comparative antioxidant and anti-inflammatory effects of 6-gingerol, 8-gingerol, and 10-gingerol and 6-shogaol. J Ethnopharm 127: 515-520.